Latest Stock Buy or Sell? Make More Informed Decisions!
Today, Stan Wong commented about whether V-N, LVMUY-OTC, IXG-N, IBM-N, ABBV-N, MSFT-Q, AMZN-Q, MDT-N, MBGYY-OTC, F-N, GM-N, UNH-N, EQRR-Q, MFC-T, PFE-N, IXJ-N, HHL-T, SQ-N, PYPL-Q, JPM-N, WFC-N, ZWC-T, XEI-T, CNQ-T, SU-T, SHEL-N, SPYD-N are stocks to buy or sell.
- Page 2/3
- Next Page
DON'T BUY
ZWC vs. XEI Basket of high-dividend paying, large cap names in Canada, with covered call overlay. Pipelines, banks, telecom. XEI has outperformed ZWC, even though ZWC has a higher yield. What happens is that you get called out of ZWC with the covered calls, so the capital appreciation is weaker. Underperformed the TSX. Higher MER of 72 bps. If you think market's moving forward, prefers XEI unless you need the extra income from covered calls. Already tax-efficient, so efficiencies would be lost in a registered account. Yield is around 6.8%.
E.T.F.'s
BUY
WFC vs. JPM Likes its relatively low book-to-value valuation compared to other large US banks. Yield is 2.78%. He likes JPM as well, but he really likes the value of WFC. You want to start to be overweight US and global financials. Improving macro picture, and you're not going to have a bull market without financials. See his Top Picks.
banks
WEAK BUY
JPM vs. WFC Likes WFC's relatively low book-to-value valuation compared to other large US banks, and a yield of 2.78%. He likes JPM as well, but he really likes the value of WFC. You want to start to be overweight US and global financials. Improving macro picture, and you're not going to have a bull market without financials. See his Top Picks.
Financial Services
COMMENT
PYPL vs. SQ - which to sell? Tough. He's significantly underweight tech. Shares of both are in a basing pattern, below respective 200-day MAs. Might be an opportunity, but who knows how long they'll base? Neither shows great technical strength. 3x price to sales, while SQ is 2.2x. More growth with SQ, but PYPL is less volatile and revenue/earnings a bit more predictable. If economy wobbles, SQ is in trouble as it depends on much smaller merchants. Many people have returned to shopping in person, so e-payments are not as popular. Both underperforming S&P. For more stability, keep PYPL. For higher growth but also volatility, keep SQ.
0
COMMENT
SQ vs. PYPL - which to sell? Tough. He's significantly underweight tech. Shares of both are in a basing pattern, below respective 200-day MAs. Might be an opportunity, but who knows how long they'll base? Neither shows great technical strength. PYPL is 3x price to sales, while SQ is 2.2x. More growth with SQ, but PYPL is less volatile and revenue/earnings a bit more predictable. If economy wobbles, SQ is in trouble as it depends on much smaller merchants. Many people have returned to shopping in person, so e-payments are not as popular. Both underperforming S&P. For more stability, keep PYPL. For higher growth but also volatility, keep SQ.
Technology
PAST TOP PICK
PAST TOP PICK
(A Top Pick Jan 12/22, Up 4%) Very good cashflow dividend of 5.2% today. Trades below book value, .95 price to book. Outpacing TSX since last May, a good technical sign. Remains a top 3 pan-Asian life insurer. Growth of middle class long term a definite positive. Looser China Covid rules will spur sales. Keep holding.
insurance
HOLD
A leader. Always outperforms the S&P 500. Healthcare performed quite well last year, and now there's a bit of rotation out and into higher beta names. Next 12-18 months, you still want healthcare in your portfolio. Defensive capabilities along with growth. 20x forward earnings, 12% growth rate. Yield is 1.3%, which will grow.
medical services
